Stryker vs. Zimmer Biomet vs. J&J in Q4: How 3 orthopedic companies compare

Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter financial results for 2024 and data on their spine orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $6.4 billion (+10.7%)

Orthopedics: $2.5 billion (10.8%)

Hips: $463 million (+11.6%)

Knees: $687 million (+9%)

Spine: $186 million (+3.2%)

Net earnings: $500 million 

Zimmer Biomet

Total sales: $2 billion (+4.3%)

Hips: $520 million (+3%)

Knees: $839.2 million (+5.1%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $489 million (+8%)

Net earnings: $239.4 million

Johnson & Johnson

Total sales: $22.5 billion (+5.3%)

Orthopedic: $2.3 billion (+2.1%)

Spine, sports and other: $735 million (-0.9%)

Hips: $418 million (+5.2%)

Knees: $398 million (3.2%)

Net earnings: $3.4 billion

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.